Juan Hincapie-Castillo, Pharm.D., M.S., Ph.D.

Juan Hincapie-Castillo

Assistant Professor

Pharmaceutical Outcomes and Policy

OFFICE: HPNP 2338

EMAIL: j.hincapie@cop.ufl.edu

PHONE: 352-273-5526

CV: Link to CV

 

Education

  • Ph.D., Pharmaceutical Outcomes & Policy, University of Florida
  • M.S., Pharmaceutical Outcomes & Policy, University of Florida
  • Pharm.D., University of Florida

Biographical sketch

Juan M. Hincapie-Castillo, Pharm.D, M.S., Ph.D., joined the Department of Pharmaceutical Outcomes and Policy as an assistant professor in 2019. He is an alumn of the University of Florida College of Pharmacy where he received the degrees of Doctor of Pharmacy (2013), Master of Science in Pharmaceutical Sciences (2017), and Ph.D. with a concentration in pharmacoepidemiology (2019). During his doctoral training, Dr. Hincapie-Castillo was appointed as a graduate fellow for the American Association of Hispanics in HigherEducation, and he was the recipient of the University of Florida Graduate Student Teaching Award in 2016. His doctoral dissertation focused on evaluating the unintended consequences of policies aimed to address the opioid crisis on acute pain management outcomes. His research interests include the study of drug utilization and safety in the area of pain management, the evaluation of the effects of State and Federal laws on patient outcomes (legal epidemiology), and the assessment of patient safety and quality for inpatient pain management.

 

Professional Affiliations

  • International Society of Pharmacoepidemiology
  • International Association for the Study of Pain
  • American Pain Society

Research Interests

  • Pharmacoepidemiology
  • Drug utilization and safety in pain management
  • Health services research and legal epidemiology
  • Patient safety and quality of inpatient pain management

 

Select Publications

  1. Hincapie-Castillo JM, Henriksen C, Staley B, Saidi A, Lipori G, Winterstein AG. Development of a Predictive Model for Drug-induced QT Prolongation in the Inpatient Setting Using EHR Data. (Am J Health Syst Pharm – Accepted 02/27/2019)
  2. Hincapie-Castillo JM, Wei J, Winterstein AG. Clinical utility and perils of prescription drug monitoring program-based alert systems (Letter to Editor). PAIN. 2018; 159(4):804-805. PMID: 29557901
  3. Soria-Saucedo R, Liu X, Hincapie-Castillo JM, Zambrano D, Bussing R, Winterstein AG. Prevalence, time trends and utilization patterns of psychotropic polypharmacy: Evidence from children and adolescent Medicaid beneficiaries, 1999-2010. Psychiatr Serv. 2018 Aug 1;69(8):919-926. PMID: 29879872
  4. Mooorman-Li R, Hincapie-Castillo JM.Chapter 31: Pain management Medication Therapy Management Data Set. In Whalen K and Hardin H. Medication Therapy Management: A pharmacotherapy and Medication System Primer. McGraw-Hill Companies, INC. 2018
  5. Hincapie-Castillo JM,Daniels PF. Use of lithium in patients with unipolar depression (Correspondence). Lancet Psychiatry. 2017; 4(9):662 PMID: 28853406
  6. Winterstein AG, Staley B, Henriksen C, Xu D, Lipori G, Jeon N, Choi Y, Li Y, Hincapie-Castillo JM, Soria-Saucedo R, Brumback B, Johns T. Development and validation of a Complexity-Score to rank hospitalized patients at risk for preventable adverse drug events. Am J Health Syst Pharm. 2017; 74(23):1970-1984. PMID: 29167139
  7. Liu X, Hatton R, Hincapie-Castillo JM,Zhu Y, Bussing R, Barnicoat M, Winterstein AG. Consistency of psychotropic drug–drug interactions listed in drug monographs. J Am Pharm Assoc. 2017; 57(6):698-703.e2. PMID: 28844584
  8. Hincapie-Castillo JM,Liu X, Bussing R, Winterstein AG. Prevalence of psychotherapy surrounding initiation of psychotropic medication polypharmacy in the Medicaid-insured population, 1999-2010. Psychiatr Serv. 2017; 68(11):1120-1126. PMID: 28669287
  9. Jeon N, Staley B, Klinker KP, Hincapie-Castillo JM,Winterstein AG. Acute Kidney Injury Risk Associated with Piperacillin-Tazobactam compared with Cefepime during Vancomycin Therapy in Hospitalized Patients: Cohort Study stratified by Baseline Kidney Function. Int J Antimicrob Agents. 2017; 50(1):63-67. PMID: 28522340
  10. Choi Y, Hincapie-Castillo JM.Bariatric surgery and risk for perinatal complications (Letter to Editor). JAMA Surg. 2017; 152(6):607-608 PMID: 28329328
  11. Moorman-Li R, Gilbert B, Orman A, Aldridge P, Leger-Krall S, Anderson C, Hincapie-Castillo JM.Evaluating the effects of diffused lavender in an Adult Day Care Center for patients with dementia in an effort to decrease behavioral issues: A Pilot Study. J Drug Assess. 2017; 6(1):1-5. PMID: 28265482
  12. Mooorman-Li R, McLin K, Hincapie-Castillo JM. Chapter 31: Pain management Medication Therapy Management Data Set. In Angaran DM and Whalen K. Medication Therapy Management: A pharmacotherapy and Medication System Primer. McGraw-Hill Companies, INC. 2015
  13. Witenko C, Moorman-Li R, Motycka C, Duane K, Hincapie-Castillo JM,Leonard P, Valaer C. Considerations for the Appropriate Use of Skeletal Muscle Relaxants for the Management of Acute Low Back Pain. P T. 2014;39(6):427-435. PMID: 25050056
  14. Winterstein AG, Hincapie-Castillo JM,Xu D, Liu W, Antonelli PJ. Ototopical Neomycin Exposure in Children with Non-Intact Tympanic Membranes. Laryngoscope. 2012; 122:2529-2532. PMID: 22965584

Additional Links

Researchgate: https://www.researchgate.net/profile/Juan_Hincapie-Castillo

Google Scholar: https://scholar.google.com/citations?user=TT2g4C0AAAAJ&hl=en

News

Dr. Juan Hincapie-Castillo invited to Rising Stars in Health-Related Sciences symposium: https://pop.pharmacy.ufl.edu/2019/04/30/dr-juan-hincapie-castillo-invited-to-rising-stars-in-health-related-sciences-symposium/